James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 50,000 shares at $25.86 ($1.3M) on 2023-03-30, disclosed to the SEC on 2023-03-31.
Open-market sale of $1.3M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |